Nemkov et al., 2021)
2006 Oct;84(4):830-4.
A 2025 systematic review published in Orthopaedic Journal of Sports Medicine , covering 36 studies from 1993 to 2024, found that BPC-157 promotes healing by boosting growth factors and reducing inflammation, with improved outcomes across muscle, tendon, ligament, and bone injury models in animals.4 The peptide enhances growth hormone receptor expression in tendon fibroblasts a key mechanism for tissue repair and regeneration.5 In the only published human orthopaedic data, seven of twelve patients with chronic knee pain reported relief lasting more than six months after a single BPC-157 injection.4 That is a small sample
2019 Sep Bernard Schmitt, Morgane Vicenzi, Catherine Garrel, Frdric M Denis
CXXC5 binds directly to Dishevelled, the upstream activator of the pathway
The peer-reviewed literature is also concentrated within a single research group (Watowich lab, University of Texas at Austin) and its industry partner Ridgeline Therapeutics, with limited independent replication to date